In this review, we will try to analyze the possible coexistence between epilepsy or seizures and type 1 diabetes mellitus (T1DM), in order to establish if there is more than a casual association, and to investigate possible mechanisms underlying this link. Anti-glutamic acid decarboxylase antibodies (GAD-Abs) have been associated with T1DM and a great number of neurological diseases such as epilepsy. Epilepsy can be a feature of a large variety of autoimmune or inflammatory disorders. GAD-Abs can have a role at the basis of the possible link between epilepsy and T1DM, although their real pathogenetic mechanism in neurological diseases is still unknown. Metabolic conditions such as hypoglycemia and hyperglycemia, common problems in diabetic patients, may be also implicated, even if their underlying mechanism is minimally understood. © 2012 European Society of Endocrinology.

Seizures and type 1 diabetes mellitus: Current state of knowledge

VERROTTI DI PIANELLA, Alberto;CHIARELLI, Francesco
2012-01-01

Abstract

In this review, we will try to analyze the possible coexistence between epilepsy or seizures and type 1 diabetes mellitus (T1DM), in order to establish if there is more than a casual association, and to investigate possible mechanisms underlying this link. Anti-glutamic acid decarboxylase antibodies (GAD-Abs) have been associated with T1DM and a great number of neurological diseases such as epilepsy. Epilepsy can be a feature of a large variety of autoimmune or inflammatory disorders. GAD-Abs can have a role at the basis of the possible link between epilepsy and T1DM, although their real pathogenetic mechanism in neurological diseases is still unknown. Metabolic conditions such as hypoglycemia and hyperglycemia, common problems in diabetic patients, may be also implicated, even if their underlying mechanism is minimally understood. © 2012 European Society of Endocrinology.
2012
Inglese
ELETTRONICO
167
6
749
758
10
Department of Pediatrics, University of Chieti, Via Dei Vestini 5, 66013 Chieti, Italy
4 aminobutyric acid, glucose, glutamate decarboxylase antibody, insulin; antibody titer, autoimmunity, diabetic ketoacidosis, disease association, EEG abnormality, epilepsy, glycemic control, human, hyperglycemia, hypoglycemia, insulin dependent diabetes mellitus, pathogenesis, prevalence, priority journal, review, seizure; Adolescent, Adult, Animals, Autoantibodies, Diabetes Mellitus; Type 1, Epilepsy, Female, Glutamate Decarboxylase, Humans, Male, Seizures, Young Adult
http://www.scopus.com/inward/record.url?eid=2-s2.0-84869053372&partnerID=40&md5=0d58c694f5985b6f9c550fd5e538f917
4
info:eu-repo/semantics/article
262
VERROTTI DI PIANELLA, Alberto; A., Scaparrotta; C., Olivieri; Chiarelli, Francesco
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/440313
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 50
  • ???jsp.display-item.citation.isi??? 47
social impact